Rapamycin in Relapsed Acute Lymphoblastic Leukemia.
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2016
At a glance
- Drugs Sirolimus (Primary) ; Corticosteroids; Corticosteroids
- Indications Acute lymphoblastic leukaemia
- Focus Pharmacodynamics
- 01 Aug 2016 Status changed from active, no longer recruiting to completed.
- 12 Feb 2016 Planned End Date changed from 1 Oct 2015 to 1 Apr 2016, according to ClinicalTrials.gov record.
- 24 Apr 2013 Planned end date changed from 1 Oct 2012 to 1 Oct 2013 as reported by ClinicalTrials.gov.